QuantAbundanciaAbundância, quantificada.

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

23,585 signal articles · 315 in last 24h · 112,405 total before filter · latest 1h ago
315last 24h
2132last 7d
379● bullish (7d)
186● bearish (7d)
204publishers
AllMacro296Earnings1213M&A90Regulatory23Product13Analyst20
✕ clear all filtersticker: MRKsentiment: bullishSentiment:bullishneutralbearishshow all (incl. clickbait)
Gilead (GILD) Wins FDA Approval for Trodelvy in TNBC
Insider Monkey46d agobullish
Gilead (GILD) Wins FDA Approval for Trodelvy in TNBC

Gilead Sciences, Inc. (NASDAQ:GILD) is one of the 12 Most Profitable S&P 500 Stocks to Invest In. On June 25, 2026, the Food and Drug Administration approved Trodelvy from Gilead Sciences, Inc. (NASDAQ:GILD) for two indications in adults with triple-negative breast cancer. The first approval covers sacituzumab govitecan-hziy as a single agent for the first-line […]